iGMDRD480

Canonical SMILES: CCN1CCN(CC1)CC(=O)NC2=C3C4=CC=CC=C4SC3=C(C=C2)C5=CC=CC6=C5OC(=CC6=O)N7CCOCC7

InChI: InChI=1S/C33H34N4O4S/c1-2-35-12-14-36(15-13-35)21-29(39)34-26-11-10-23(33-31(26)25-6-3-4-9-28(25)42-33)22-7-5-8-24-27(38)20-30(41-32(22)24)37-16-18-40-19-17-37/h3-11,20H,2,12-19,21H2,1H3,(H,34,39)

InChI Key: AATCBLYHOUOCTO-UHFFFAOYSA-N

Loading, please wait...
Standard Name
CHEMBL
Pubchem CID
Drug Status
Drug Type
Standard NameKU0060648
CHEMBLCHEMBL1086377
Pubchem CID11964000
Drug StatusAlone
Drug TypeSmall Molecule

Drug Targets:

PRKDC

Drug-model tissue-cancer distribution: Bubble Plot

undefinetissue: undefine cancer: undefined model num: 0undefinedtissue: undefined cancer: PANCAN model num: 51BOWEtissue: BOWE cancer: BOWEL model num: 0BOWELtissue: BOWEL cancer: undefined model num: 13LUNtissue: LUN cancer: LUNG model num: 0LUNGtissue: LUNG cancer: undefined model num: 1LIVEtissue: LIVE cancer: LIVER model num: 0LIVERtissue: LIVER cancer: undefined model num: 1OTHEtissue: OTHE cancer: OTHER model num: 0OTHERtissue: OTHER cancer: Cancer of Unknown Primary (CUP) model num: 1

Drug-gene pathway enrichments

Drug-gene GO enrichments

Drug-Gene: Aster Plot


Loading, please wait...
Gene ID
Gene Name
Model Num.
2200 FBN1 1
7253 TSHR 2
1387 CREBBP 1
55728 N4BP2 3
Showing 1 to 4 of 26 rows rows per page

Gene in drug-gene network: Network Plot

tipifarnib-P2tipifarnib-P2neopeltolideneopeltolidebrefeldin.Abrefeldin.AquinoclaminequinoclaminenavitoclaxnavitoclaxPIK-75PIK-75triacsin Ctriacsin CSCH-529074SCH-529074ABT737ABT737tanespimycintanespimycinRo 28-1675Ro 28-1675ursolic acidursolic acidChloropentafluorobenzeneChloropentafluorobenzeneCHM-1CHM-1TGTGselumetinib in BRAF mutant tumorsselumetinib in BRAF mutant tumorsML 210ML 210parbendazoleparbendazoleLY 2183240LY 2183240AACOCF3AACOCF3Tyrphostin AG 1478Tyrphostin AG 1478pevonedistatpevonedistatLexibulinLexibulin(1S,3R)-RSL3(1S,3R)-RSL3indisulamindisulamcurcumincurcuminFqi1Fqi1CNTRLCNTRLSN-38SN-38MST-312MST-312cytochalasin.Bcytochalasin.BBRD63610BRD63610BIX01294BIX01294NSC141540NSC141540CD437CD437CHL1CHL1cetuximabcetuximabPI3K pathway inhibitors (alone or in combination)PI3K pathway inhibitors (alone or in combination)EverolimusEverolimusisoevodiamineisoevodiaminetosedostattosedostatoligomycin.Aoligomycin.AML214ML214triptolidetriptolidePI3K pathway inhibitorsPI3K pathway inhibitorsBRD7137BRD7137BYL719 (Alpelisib)BYL719 (Alpelisib)trastuzumab alonetrastuzumab alonePIK3CAPIK3CAPD0325901PD0325901WWTR1WWTR1PX 12PX 12NSC95397NSC95397avrainvillamideavrainvillamideNsc 632839Nsc 632839piperlonguminepiperlonguminePAC-1PAC-1FQI-2FQI-2BIRC6BIRC6Compound 44Compound 44RITARITABMS-536924BMS-536924BRD4132BRD4132BRD4354BRD4354CHEMBL1434137CHEMBL1434137tamatinibtamatinibgossypolgossypolFLNBFLNBPRL-3 Inhibitor IPRL-3 Inhibitor IIdarubicinIdarubicinlovastatin acidlovastatin acidSepantroniumSepantroniumNPC26NPC26MGAMGAAZD-1775AZD-1775Merck60Merck60leucascandrolide Aleucascandrolide ACompound 10b [PMID: 11504634]Compound 10b [PMID: 11504634]nutlin 3nutlin 3PDE4DIPPDE4DIPMEK inhibitorsMEK inhibitorsCobimetinibCobimetinibSorafenibSorafenibPanitumumabPanitumumabBRAF inhibitorsBRAF inhibitorspan-RAF inhibitorspan-RAF inhibitorsPLX-4720PLX-4720DabrafenibDabrafenibVemurafenibVemurafenibRefametinibRefametinibTrametinibTrametinibBRAFBRAFDC-45-A2DC-45-A2ML162ML162SB225002SB225002ABT-751ABT-751ZNF331ZNF331rotenonerotenoneFK 866FK 866manumycin.Amanumycin.AGMX1778GMX1778BRD4770BRD4770Compound.23.citrateCompound.23.citrateNANOS2NANOS2PRIMA-1PRIMA-1ceruleninceruleninFedratinibFedratinibchaetocinchaetocinEEF2KEEF2K179324-69-7179324-69-7SCHEMBL2608041SCHEMBL2608041FBN1FBN1kinetin ribosidekinetin ribosideBRD6368BRD6368importazoleimportazoleN4BP2N4BP2CHEMBL399379CHEMBL399379itraconazoleitraconazoleTGX-115TGX-115VX-680VX-680teniposideteniposideMK-2206MK-2206RIPK3RIPK3ISX-9ISX-9BI-2536BI-2536GemcitabineGemcitabinePREX2PREX2NeratinibNeratinibCompound.1541ACompound.1541ACyanoquinoline, 11Cyanoquinoline, 11AM-580AM-580CIL41CIL41BRD9876BRD9876SirolimusSirolimusBax.channel.blockerBax.channel.blockerMYH10MYH10GW-843682XGW-843682Xbistramide Abistramide AOlaparibOlaparibATMATMPD-0325901PD-0325901PYGBPYGBQuiflaponQuiflaponParthenolideParthenolideCompound.7d.cisCompound.7d.cispifithrin-mupifithrin-muPRIMA-1METPRIMA-1METCREBBPCREBBPsalermidesalermidenakiterpiosinnakiterpiosinSMR000068650SMR000068650PXKPXKSTARSTARETS1ETS1NSC23766NSC23766OBSCNOBSCNGW-405833GW-405833TSHRTSHRKU0060648KU0060648

Models in KU0060648

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​

SITE
DATATYPES
CLASSFICATION
Map

Copyright © 2018 Modellab | All Rights Reserved

Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.